{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:17:37Z","timestamp":1719015457680},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Amoxicillin\/clavulanate is a commonly used antibiotic. Though relatively rare, amoxicillin\/clavulanate carries the highest incidence of idiosyncratic drug-induced liver disease. This case report presents an 80-year-old woman treated for simple respiratory tract infection with amoxicillin\/clavulanate who was subsequently hospitalized with malaise and icterus and a biochemical cholestatic pattern with high alkaline phosphatase and bilirubin. Diagnostically challenging, ultimately, liver biopsy revealed drug-induced liver injury with a fatal course after attempt of supportive, symptomatic treatment.<\/jats:p>","DOI":"10.61409\/v02240094","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T08:24:04Z","timestamp":1718007844000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["Severe hepatic cholestasis after treatment with amoxicillin\/clavulanic acid"],"prefix":"10.61409","author":[{"given":"Michelle","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Lykke","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"deLemos AS, Ghabril M, Rockey DC et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61(8):2406-2416. https:\/\/doi.org\/10.1007\/s10620-016-4121-6","DOI":"10.1007\/s10620-016-4121-6"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419-25. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.006","DOI":"10.1053\/j.gastro.2013.02.006"},{"key":"ref2","unstructured":"Amoxicillin-clavulanate. LiverTox. Clinical and research information on drug-induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. www.ncbi.nlm.nih.gov\/books\/NBK548517\/ (20 okt. 2020)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222-1261. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.014","DOI":"10.1016\/j.jhep.2019.02.014"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Petrov PD, Soluyanova P, S\u00e1nchez-Campos S et al. Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: role of NRF2 and FXR pathways. Food Chem Toxicol. 2021;158:112664. https:\/\/doi.org\/10.1016\/j.fct.2021.112664","DOI":"10.1016\/j.fct.2021.112664"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:33:48Z","timestamp":1718969628000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V02240094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v02240094","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]}}}